BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roli L, Pecoraro V, Trenti T. Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? Int J Biol Markers. 2017;32:e53-e61. [PMID: 28106227 DOI: 10.5301/jbm.5000245] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Celepli P, Bigat İ, Karabulut S, Celepli S, Hücümenoğlu S. Evaluation of Lipocalin-2 and Twist expression in thyroid cancers and its relationship with epithelial mesenchymal transition. Annals of Diagnostic Pathology 2022;59:151973. [DOI: 10.1016/j.anndiagpath.2022.151973] [Reference Citation Analysis]
2 Hao P, Zhang J, Fang S, Jia M, Xian X, Yan S, Wang Y, Ren Q, Yue F, Cui H. Lipocalin-2 inhibits pancreatic cancer stemness via the AKT/c-Jun pathway. Human Cell. [DOI: 10.1007/s13577-022-00735-z] [Reference Citation Analysis]
3 Flitcroft JG, Verheyen J, Vemulkar T, Welbourne EN, Rossi SH, Welsh SJ, Cowburn RP, Stewart GD. Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy. BJU Int 2021. [PMID: 34570419 DOI: 10.1111/bju.15601] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Qin WH, Liu JT, Wang SP, Yang ZS, Wang KK, Hu B. Antibody array-based proteomic screening of novel biomarkers in malignant biliary stricture. Cancer Biomark 2021. [PMID: 34542063 DOI: 10.3233/CBM-210095] [Reference Citation Analysis]
5 O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087 [PMID: 34326612 DOI: 10.3748/wjg.v27.i26.4045] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Krizanac M, Mass Sanchez PB, Weiskirchen R, Asimakopoulos A. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. Int J Mol Sci 2021;22:2865. [PMID: 33799862 DOI: 10.3390/ijms22062865] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
7 Lumlertgul N, Ostermann M, McCorkell S, van Dellen J, Williams AB. Association of plasma and urine NGAL with acute kidney injury after elective colorectal surgery: A cohort study. Ann Med Surg (Lond) 2021;62:315-22. [PMID: 33552490 DOI: 10.1016/j.amsu.2021.01.060] [Reference Citation Analysis]
8 Che K, Han W, Zhang M, Niu H. Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma. Oncol Lett 2021;21:148. [PMID: 33552266 DOI: 10.3892/ol.2020.12409] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Tsakogiannis D, Kalogera E, Zagouri F, Zografos E, Balalis D, Bletsa G. Determination of FABP4, RBP4 and the MMP-9/NGAL complex in the serum of women with breast cancer. Oncol Lett 2021;21:85. [PMID: 33376518 DOI: 10.3892/ol.2020.12346] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Carafa V, Altucci L. Deregulation of Cell Death in Cancer: Recent Highlights. Cancers (Basel) 2020;12:E3517. [PMID: 33255936 DOI: 10.3390/cancers12123517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Hao P, Li H, Wu A, Zhang J, Wang C, Xian X, Ren Q, Hao N, Wang Y, Yue F, Cui H. Lipocalin2 promotes cell proliferation and migration in ovarian cancer through activation of the ERK/GSK3β/β-catenin signaling pathway. Life Sci 2020;262:118492. [PMID: 32980390 DOI: 10.1016/j.lfs.2020.118492] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Bauvois B, Pramil E, Jondreville L, Chapiro E, Quiney C, Maloum K, Susin SA, Nguyen-Khac F. Relation of Neutrophil Gelatinase-Associated Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic Lymphocytic Leukemia. Cancers (Basel) 2020;12:E2124. [PMID: 32751884 DOI: 10.3390/cancers12082124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Gumpper K, Dangel AW, Pita-Grisanti V, Krishna SG, Lara LF, Mace T, Papachristou GI, Conwell DL, Hart PA, Cruz-Monserrate Z. Lipocalin-2 expression and function in pancreatic diseases. Pancreatology 2020;20:419-24. [PMID: 31932215 DOI: 10.1016/j.pan.2020.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Zhang X, Cui Y, He M, Jiao Y, Yang Z. Lipocalin-1 Expression as a Prognosticator Marker of Survival in Breast Cancer Patients. Breast Care (Basel) 2020;15:272-80. [PMID: 32774222 DOI: 10.1159/000503168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Du Z, Wu B, Xia Q, Zhao Y, Lin L, Cai Z, Wang S, Li E, Xu L, Li Y, Xu H, Yin D. LCN2-interacting proteins and their expression patterns in brain tumors. Brain Research 2019;1720:146304. [DOI: 10.1016/j.brainres.2019.146304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Guo P, Yang J, Huang J, Auguste DT, Moses MA. Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel. Proc Natl Acad Sci U S A 2019;116:18295-303. [PMID: 31451668 DOI: 10.1073/pnas.1904697116] [Cited by in Crossref: 27] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
17 Asimakopoulou A, Vucur M, Luedde T, Schneiders S, Kalampoka S, Weiss TS, Weiskirchen R. Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma. Cancers (Basel) 2019;11:E385. [PMID: 30893876 DOI: 10.3390/cancers11030385] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
18 Zhao Y, Xia Q, Liu Y, Bai W, Yao Y, Ding J, Lin L, Xu Z, Cai Z, Wang S, Li E, Xu H, Wu B, Xu L, Du Z. TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cells. Cell Signal 2019;55:8-16. [PMID: 30557604 DOI: 10.1016/j.cellsig.2018.12.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
19 Bartsch DK, Gercke N, Strauch K, Wieboldt R, Matthäi E, Wagner V, Rospleszcz S, Schäfer A, Franke FS, Mintziras I, Bauer C, Grote T, Figiel J, Di Fazio P, Burchert A, Reinartz S, Pogge von Strandmann E, Klöppel G, Slater EP. The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer. J Clin Med 2018;7:E295. [PMID: 30241369 DOI: 10.3390/jcm7100295] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
20 Bauvois B, Susin SA. Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner? Cancers (Basel) 2018;10:E336. [PMID: 30231474 DOI: 10.3390/cancers10090336] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
21 Tai J, Wang S, Zhang J, Ge W, Liu Y, Li X, Liu Y, Deng Z, He L, Wang G, Ni X. Up-regulated lipocalin-2 in pediatric thyroid cancer correlated with poor clinical characteristics. Eur Arch Otorhinolaryngol 2018;275:2823-8. [PMID: 30182199 DOI: 10.1007/s00405-018-5118-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 Monisha J, Roy NK, Padmavathi G, Banik K, Bordoloi D, Khwairakpam AD, Arfuso F, Chinnathambi A, Alahmadi TA, Alharbi SA, Sethi G, Kumar AP, Kunnumakkara AB. NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance. Cancers (Basel) 2018;10:E228. [PMID: 29996471 DOI: 10.3390/cancers10070228] [Cited by in Crossref: 35] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
23 Molina L, Bell D, Tao J, Preziosi M, Pradhan-Sundd T, Singh S, Poddar M, Luo J, Ranganathan S, Chikina M, Monga SP. Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in Hepatoblastoma. Am J Pathol 2018;188:1895-909. [PMID: 29920228 DOI: 10.1016/j.ajpath.2018.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Meng L, Wang M, Du Z, Fang Z, Wu B, Wu J, Xie W, Shen J, Zhu T, Xu X, Liao L, Xu L, Li E, Lan B. Cell Signaling Pathway in 12-O-Tetradecanoylphorbol-13-acetate-Induced LCN2 Gene Transcription in Esophageal Squamous Cell Carcinoma. Biomed Res Int 2017;2017:9592501. [PMID: 29098164 DOI: 10.1155/2017/9592501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]